PATENT CLAIM ANALYSIS

Application Number: 16248422
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-09
Patent Classification: ["514", "009200"]

Abstract:
The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.

Claim (Index 31):
The method of  claim 21 , wherein the human is experiencing basal epithelial cell death.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15239460', '14456202', '15702186', '13471689', '14836177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8697557422625267
- 35 USC 102 Novelty (BERT): 0.5755264522080138
- Combined Prediction Score: 0.8403328132570754
- Mean Citation Score: 474.624424
- Max Citation Score: 486.23077
- Similarity Product: 268.0739148098594

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test